Singapore Manufacturing Output Rises in April Powered by AIDriven Demand How AIDriven NBFCs Are Reshaping Indias Credit Landscape Amazon Faces Allegations of Profiting from NowIllegal Policy Report Claims AIDriven Job Applications Creating Doom Loop for Recruiters and Candidates Says Greenhouse CEO IRFC Secures 13527 Crore Refinancing Deal for Hyderabad Metro Expansion AutoNation TJX Alibaba Lead Market Moves A Sector Overview PLDT Inc PHI Q1 2026 Earnings EPS Misses Estimates as Stock Inches Higher COCH Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress Though Revenue Absence Raises Questions AMWD Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction RRC Q1 2026 Earnings EPS Surges Past Estimates with 19 Beat Amid Strategic Operations Senti Biosciences Inc Q1 2026 Earnings Narrowing Losses and Gene Circuitry Progress BOLT Q1 2026 Earnings EPS Misses Estimates on Higher RD Costs Stock Edges Up Velocity Financial VEL Consolidates Near 1743 as Traders Eye Support and Resistance Levels Repligen Corporation RGEN Edges Higher as Bioprocessing Sector Shows Signs of Stabilization AbCellera Biologics ABCL Bounces from Support Biotech Stock Gains 173 on Renewed Interest Swarmer Inc SWMR Surges 1268 Breakout Momentum or Overbought Risk FACT II Acquisition Corp Holds Steady Near Resistance as SPAC Market Awaits Catalyst Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond FFBC Q1 2026 Earnings EPS Surpasses Estimates by 8 Strengthening Investor Confidence BrandywineGLOBAL Global Income Opportunities Fund BWG Edges Lower Testing Support Zone SOBR Safe Inc SOBR Q3 2025 Earnings Loss Per Share Widens Amid Operational Challenges PNC Q1 2026 Earnings Modest EPS Beat Reflects Resilient Core Operations NX Q1 2026 Earnings Earnings Beat Estimates Despite Negative EPS DK Q1 2026 Earnings Narrow Profit Beats Deeply Negative Estimates SPIR Q1 2026 Earnings EPS Misses Estimates as Stock Surges 1224 IDN Q1 2026 Earnings EPS Surges Past Estimates Stock Dips Despite Strong Beat CNTB Q1 2026 Earnings Significant EPS Miss as Biotech Continues PreRevenue Phase